Clinical Trial Update: Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148 [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial of brexpiprazole for irritability in children and adolescents with autism spectrum disorder has completed participation and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• REXULTI (brexpiprazole)
• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Irritability Associated With Autism Spectrum Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-05-30